Case Activity (5539)

1. Order | Filed: August 31, 2026 | Entered: August 31, 2026 Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals U.S.A., Inc.

   Patent | Delaware

   Order Setting Teleconference

   ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Disputes Regarding Updating Expert Damages Reports (D.I. 380 ). A discovery dispute teleconference is scheduled for September 16, 2026 at 3:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than September 4, 2026, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than September 10, 2026, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Jennifer L. Hall on 8/31/2026. (ceg)

2. Order | Filed: August 31, 2026 | Entered: August 31, 2026 VANDA PHARMACEUTICALS INC. v. FOOD AND DRUG ADMINISTRATION et al

   Other Statutory Actions | District Of Columbia

   Order on Motion to Modify Set/Reset Deadlines

   MINUTE ORDER granting Federal Defendants' 79 Unopposed Motion to Modify Scheduling Order. Federal Defendants and Intervenor-Defendant shall file their replies in support of their cross-motions for summary judgment by September 8, 2026. Plaintiff shall file the joint appendix by September 29, 2026. Signed by Judge Christopher R. Cooper on 8/31/2026. (lccrc1)

3. 5537 additional result(s)